Astrimmune - Implementation and Validation of a novel test for pancreatic and other gastrointestinal cancers based on shed tumour cells in the blood
Astrimmune is developing a diagnostic test for pancreatic and other gastrointestinal cancers based on detection and profiling of shed tumour cells in the blood. Requiring only 6ml of blood, the test p...
- Funding £1,095,180
- Competition Cancer
- Competition Date Autumn 2013
- Local AHSN East Midlands AHSN
- Status On Market